(AP5) AP5 supports the overall mission of this ICBG - discovering and developing therapeutic agents to treat invasive fungal infections and cancer - in several ways: dereplicating active compounds from bacterial extracts, discovering metabolites identified by genome mining, providing follow-up chemistry, housing the anticancer therapeutic discovery pipeline, administering overall group activities, and assisting in the development of both scientific personnel and research infrastructure in Brazil. These activities are embodied in four specific aims described below. 1. Identify and supply active molecules and derivatives to the antifungal and anticancer screening platforms. AP5 will speed up this traditional bottleneck by waiting for potency/selectivity data before beginning dereplicaton, using NMR techniques on partially purified fractions, and trying an new approach to high- throughput crystallography. 2. AP5 will also carry out studies to identify cryptic metabolites - molecules whose biosynthetic genes can be identified but that have never been characterized. AP5 will use two approaches: elicitor/co-culture stimulation and genetic knockouts coupled with differential metabolomics. 3. A high-throughput anticancer drug discovery pipeline that runs from primary assays to in vivo studies will be used to identify small molecules with therapeutic potential for blood cancers. These assays utilize 24 cell lines from 6 types of blood cancer, and all cell lines have been genomically characterized so that initial phenotypic screening results can reveal something about mechanism. 4. AP5 will also carry out many of the administrative functions: research agreements, database, communications, and training.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19TW009872-01
Application #
8785547
Study Section
Special Emphasis Panel (ZRG1-BCMB-H (50))
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
1
Fiscal Year
2014
Total Cost
$23,301
Indirect Cost
$8,687
Name
Harvard Medical School
Department
Type
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
Paludo, Camila R; Ruzzini, Antonio C; Silva-Junior, Eduardo A et al. (2016) Whole-Genome Sequence of Bacillus sp. SDLI1, Isolated from the Social Bee Scaptotrigona depilis. Genome Announc 4:
Ruzzini, Antonio C; Clardy, Jon (2016) Gene Flow and Molecular Innovation in Bacteria. Curr Biol 26:R859-64
Ramadhar, Timothy R; Zheng, Shao Liang; Chen, Yu Sheng et al. (2015) Analysis of rapidly synthesized guest-filled porous complexes with synchrotron radiation: practical guidelines for the crystalline sponge method. Acta Crystallogr A Found Adv 71:46-58
Sit, Clarissa S; Ruzzini, Antonio C; Van Arnam, Ethan B et al. (2015) Variable genetic architectures produce virtually identical molecules in bacterial symbionts of fungus-growing ants. Proc Natl Acad Sci U S A 112:13150-4
Van Arnam, Ethan B; Ruzzini, Antonio C; Sit, Clarissa S et al. (2015) A Rebeccamycin Analog Provides Plasmid-Encoded Niche Defense. J Am Chem Soc 137:14272-4
Ramadhar, Timothy R; Zheng, Shao-Liang; Chen, Yu-Sheng et al. (2015) The crystalline sponge method: MOF terminal ligand effects. Chem Commun (Camb) 51:11252-5